Clinical Trial of Recombinant Pneumococcal Protein Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 11, 2023

Primary Completion Date

September 14, 2023

Study Completion Date

January 30, 2024

Conditions
PneumoniaRespiratory Tract DiseasesRespiratory Tract Infections
Interventions
BIOLOGICAL

PBPV

Intramuscular injection, 1 dose of 0.5ml inoculated on day 0

BIOLOGICAL

PPV23

Intramuscular injection, 1 dose of 0.5ml inoculated on day 0

Trial Locations (1)

Unknown

Lancang Lahu Autonomous County Center for Disease Control and Prevention, Puer

Sponsors
All Listed Sponsors
lead

CanSino Biologics Inc.

INDUSTRY